NT-proBNP Rapid Test: A POCT Tool for Heart Failure Diagnosis and Prognostic Assessment

As a core marker for heart failure diagnosis and prognostic assessment, it is widely used in European heart failure diagnosis and treatment pathways, supporting rapid assessment and triage in emergency departments and outpatient clinics.

Accurately Identifying Heart Failure: The Clinical Value of NT-proBNP Testing

Heart failure (Heart Failure, HF) is a complex clinical syndrome and the terminal stage of various heart diseases. Early and accurate diagnosis of heart failure, assessment of its severity, and monitoring of treatment response are crucial for improving patient prognosis and quality of life. N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a hormone precursor released by ventricular myocytes when ventricular wall tension increases or volume load is excessive. Its plasma concentration is closely related to the degree of cardiac dysfunction and has become one of the internationally recognized "gold standard" biomarkers for heart failure diagnosis and prognostic assessment.

Advantages of reOpenTest NT-proBNP Rapid Test

Rapid auxiliary diagnosis of heart failure

For patients with suspected heart failure symptoms such as dyspnea, rapid testing of NT-proBNP helps to quickly distinguish between cardiac and non-cardiac causes, improving diagnostic accuracy.

Assessing the severity of the condition and prognosis

NT-proBNP levels are significantly correlated with the severity of heart failure (such as NYHA classification) and the patient's short-term and long-term prognosis.

POCT platform, instant and convenient

Point-of-care testing (POCT) design allows for rapid results (e.g., 15-20 minutes) in the emergency room, outpatient clinic, or even at the bedside, without waiting for the central laboratory.

Optimize patient triage and management

Supports rapid assessment and triage of suspected heart failure patients in the emergency department and outpatient clinic, guiding subsequent treatment strategies and monitoring treatment response.

Clinical application scenarios

The reOpenTest NT-proBNP rapid test is widely applicable to:

Differential diagnosis of acute dyspnea patients in the emergency department.
Preliminary screening and diagnosis of suspected chronic heart failure patients in the outpatient clinic.
Assessment of disease severity and risk stratification in patients with confirmed heart failure.
Monitoring of treatment effects and reference for drug adjustment in heart failure patients.
Preliminary assessment of cardiac function in high-risk groups for cardiovascular disease.

By providing reliable and convenient NT-proBNP rapid testing, reOpenTest is committed to assisting clinicians in managing heart failure patients more effectively and improving their clinical outcomes.

Get NT-proBNP Rapid Testing Solutions

Learn more about reOpenTest NT-proBNP rapid test products and their application details in heart failure diagnosis and treatment.